Drugs / Novartis Investigational H5N1 vaccine
last change Apr 2015 re-read 3 minutes ago

Novartis Investigational H5N1 vaccine

Vaccine

Developed for
influenza
Investigated by
Novartis Vaccines · Seqirus

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02091908 Apr 2014 → Apr 2015 influenza Seqirus Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Novartis Investigational H5N1 vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02091908 ↗
Modality Vaccine “Novartis Investigational H5N1 vaccine” NCT02091908 ↗